Phase 2
N=36
Improving Therapeutic Learning in Depression: Proof of Concept
Major Depressive Disorder
Bottom Line
View on ClinicalTrials.gov: NCT02376257 ↗Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Sep 2018
Primary outcome: Primary: Recall of Cognitive Therapy Content — 25.4; 26.8; 24.7; 28.2 Number of correct units of information
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- 250 mg DCS (Drug); 100 mg Modafinil (Drug); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston University Charles River Campus
- Primary completion
- Apr 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Recall of Cognitive Therapy Content |
25.4; 26.8; 24.7; 28.2; 29.7; 28.7 | — |
| PRIMARY 1 Week Delayed Recall of Emotional Story Items |
13.5; 21.3; 16.1; 25.0; 37.3; 26.4 | — |
| PRIMARY 1 Week Delayed Recall Logical Memory |
1.8; 4.4; 5.0; 9.5; 12.8; 13.6 | — |
| SECONDARY Logical Memory Immediate Recall |
14.8; 17.1; 16.2; 17.7; 17.8; 18.2 | — |
| SECONDARY Immediate Memory Measured by the Hopkins Verbal Learning Task |
8.5; 9.6; 9.6; 7.8; 9.9; 9.4 | — |
| SECONDARY Immediate Recall of Emotional Story Items |
22.4; 35.2; 32.2; 34.4; 46.8; 35.5 | — |
| SECONDARY Skills of Cognitive Therapy |
23.3; 20.5; 24.8; 26.4; 24.3; 25.7 | — |
| SECONDARY Digits Backward |
8.3; 9.5; 11.3; 9.25; 10.4; 12.2 | — |
Summary
Despite advances in both pharmacotherapy and psychotherapy for major depression, non-response and partial-response remain relatively common outcomes, motivating the search for new treatments. This study is concerned with the development of one such novel treatment, the augmentation of exposure-based cognitive-behavior therapy (CBT) with d-cycloserine (DCS).
Eligibility Criteria
Inclusion Criteria
- Must have a DSM diagnosis of major depression as determined by structured diagnostic interview
- Must be free of psychotropic medications other than serotonin selective reuptake inhibitors (SSRIs) for at least 2 weeks
- No current suicidal ideation
- Able to speak and understand English
- Must be between the ages of 18 and 65, inclusive
- Must be a male, or a female who is not of childbearing potential (i.e., surgically sterile, postmenopausal for at least 1 year) or who is non-pregnant, non-lactating and using a medically accepted method of contraception. Acceptable methods of contraception include condoms (male or female) with or without a spermicidal agent, diaphragm or cervical cap with spermicide, medically prescribed IUD, hormonal contraceptives. A woman of childbearing potential who is not currently sexually active must agree to use a medically accepted method of contraception should she become sexually active while participating in the trial
Exclusion Criteria
- A DSM diagnosis of dementia, neurodegenerative disease, or other organic mental disorder; substance use disorder other than nicotine or caffeine in the last 3 months; bulimia or anorexia within the last 3 months; lifetime history of psychotic disorder or, bipolar disorder, or developmental disorder;
- A diagnosis of organic brain syndrome, mental retardation, or other cognitive dysfunction that could interfere with a participants capacity to participate in CBT or to complete safety and efficacy assessments
- A history of seizures (apart from childhood febrile seizures) or head trauma causing ongoing cognitive impairment
- An uncontrolled, unstable clinically significant medical condition (e.g., renal, endocrine, hepatic, respiratory, cardiovascular, hematologic, immunologic or cerebrovascular disease, or malignancy, or poorly controlled hypertension (> 150/90mmHg) that may interfere with the interpretation of safety and efficacy evaluations in the opinion of the study physician or investigator
- Medical illness including hypertension, cardiac disease, liver disease, pulmonary diseases, central nervous system disease, and epilepsy;
- Recent (1 year) suicidal attempts or current suicidal ideation
- For women, currently pregnant, plans to be pregnant in the next 2 months, or currently breastfeeding
- Treatment with phenytoin, isoniazid, or propranolol or known sensitivity to modafinil or cycloserine
- A history of head trauma causing loss of consciousness, seizure or ongoing cognitive impairment
- Use of psychotropic medication (including stimulants) other than SSRIs
- Current daily use of alcohol or regular binge alcohol use as determined on the medical screen
- Insufficient command of the English language (i.e., cannot carry on a conversation with an interviewer in the English language or read associated text)
- Receipt of CBT in the previous five years
Data sourced from ClinicalTrials.gov (NCT02376257). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.